AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Mike Dorning
WASHINGTON _ Top officials at the Food and Drug Administration already had decided not to allow over-the-counter sales of a controversial "morning-after" contraceptive months before the agency's safety review was completed, according to documents and accounts from several FDA officials contained in a new critical audit of the agency's actions.
The Government Accountability Office, Congress' investigative agency, concluded Monday that the FDA did not follow its normal procedures in handling the application to allow women easier access to the emergency contraceptive pill, which is sold under the brand name Plan B.
Nearly two years after a scientific advisory committee recommended that the emergency contraceptive be made available to women without a prescription, the FDA has yet to make a final decision.
In a review…
Source: HighBeam Research, FDA didn't follow normal procedures on contraceptive, GAO...